Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors
D Miyamoto, Masataka Miyamoto, A Takahashi et al. · Oncogene · 2008
Cited by 103 works. doi:10.1038/sj.onc.1211019
Authors
References
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
- Mechanism of activation of a human oncogene
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
- Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
- Crystal Structure of the Tyrosine Phosphatase SHP-2
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
- The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
- Germline mutations in HRAS proto-oncogene cause Costello syndrome
- SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein